EUVIMEDEUVIMED entdecken
Crossref

LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease

Zijian Zheng, Shushan Zhang, Xinjie Liu, Xiangrong Wang, Cheng Xue, Xiao Wu, Xinran Zhang, Xinping Xu, Zheng Liu, Longping Yao, Guohui Lu iD

Journal of Cellular Physiology · 2024-05 · 239 (5)

DOI: 10.1002/jcp.31250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 13.03.2024. Verfasst von Zijian Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Ferroptosis, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Microglia, Neuroinflammatory Diseases. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, The Key Project of National Natural Science Foundation of Jiangxi Province, The Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is the most prevalent neurodegenerative disorder. Neuroinflammation mediated by activated microglia and apoptosis of dopaminergic (DA) neurons in the midbrain are its primary pathological manifestations. Leucine‐rich repeat protein kinase 2 (LRRK2) kinase has been observed to increase expression during neuroinflammation, however, the effect of LRRK2 on microglia activation remains poorly understood. In this study, we have established lipopolysaccharide (LPS) treated BV2 cells and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) models for both in vivo and in vitro investigation. Our data in vivo reveal that LRRK2 can promote microglia activation by regulating ferroptosis and activating nuclear factor‐κB. Inhibition of LRRK2 expression effectively suppressed the LPS‐induced pro‐inflammatory cytokines and facilitated the secretion of neuroprotective factors. Importantly, by co‐overexpressing LRRK2 and glutathione peroxidase 4 (GPX4), we identified the system Xc‐GSH–GPX4 pathway as a crucial component in LRRK2‐mediated microglial ferroptosis and inflammatory responses. Using a microglial culture supernatant (MCS) transfer model, we found that inhibiting LRRK2 or downregulating ferroptosis in BV2 cells prevented SH‐SY5Y cell apoptosis. Additionally, we observed abundant expression of LRRK2 and P‐P65 in the midbrain, which was elevated in the MPTP‐induced PD model, along with microglia activation. LRRK2 and P‐P65 expression inhibition with PF‐06447475 attenuated microglia activation in the nigrostriatal dense part of MPTP‐treated mice. Based on our findings, it is evident that LRRK2 plays a critical role in promoting the neuroinflammatory response during the pathogenesis of PD by regulating the system Xc‐GSH–GPX4 pathway. Taken together, our data highlights the potential research and therapeutic value of targeting LRRK2 to regulate neuroinflammatory response in PD through ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MicrogliaNeuroinflammatory DiseasesParkinson DiseaseAnimalsHumansMaleMice1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineCell LineDisease Models, AnimalDopaminergic NeuronsLipopolysaccharidesMice, Inbred C57BLNF-kappa BPhospholipid Hydroperoxide Glutathione PeroxidaseSignal TransductionPyrimidinesPyrroles

Stichwörter der Autor:innen

LRRK2NF‐κBParkinson's diseaseferroptosismicroglia

Substanzen

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LipopolysaccharidesNF-kappa BPhospholipid Hydroperoxide Glutathione PeroxidaseLrrk2 protein, mouse3-(4-(morpholin-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-5-yl)benzonitrilePyrimidinesPyrroles

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Department of Neuroanatomy, Group for Regeneration and Reprogramming, Institute for Regeneration, Anatomy and Cel Biology, Medical Faculty, Heidelberg University, Heidelberg, Germany.

ORCID-Profile: Guohui Lu

Förderung

  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • The Key Project of National Natural Science Foundation of Jiangxi Province
  • The Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province

Zitieren

APA

Zheng, Z., Zhang, S., Liu, X., Wang, X., Xue, C., Wu, X., Zhang, X., Xu, X., Liu, Z., Yao, L., & Lu, G. (2024). LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease. Journal of Cellular Physiology, 239(5). https://doi.org/10.1002/jcp.31250

Vancouver

Zheng Z, Zhang S, Liu X, Wang X, Xue C, Wu X, et al. LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease. Journal of Cellular Physiology. 2024;239(5). doi:10.1002/jcp.31250

BibTeX
@article{Zheng2024,
  author = {Zheng, Zijian and Zhang, Shushan and Liu, Xinjie and Wang, Xiangrong and Xue, Cheng and Wu, Xiao and Zhang, Xinran and Xu, Xinping and Liu, Zheng and Yao, Longping and Lu, Guohui},
  title = {LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  volume = {239},
  number = {5},
  doi = {10.1002/jcp.31250}
}
Kostenlos starten →